Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan
HCT can allow immune reconstitution in congenital athymia, although long-term survival is affected by comorbidities. Early diagnosis and timely intervention are crucial in managing this condition. HCT can be a restricted alternative therapy for patients ineligible for thymus implantation.
Authors
- Motoshi Sonoda (ORCID: https://orcid.org/0000-0003-0167-3322)
- Katsuhide Eguchi (ORCID: https://orcid.org/0000-0002-6799-7971)
- Masataka Ishimura (ORCID: https://orcid.org/0000-0002-0735-6566)
- Hideki Muramatsu (ORCID: https://orcid.org/0000-0002-8801-0021)
- Koji Kawaguchi (ORCID: https://orcid.org/0000-0002-4612-4047)
- Tsubasa Nishinosono (ORCID: https://orcid.org/0009-0003-0558-1916)
- Takeshi Yamamoto
- Manabu Wakamatsu
- Takahiro Kudo
- Michiko Kajiwara
- Yoshiyuki Takahashi
Institutions
- Kyushu University (JP)
- Chiba University (JP)
- Juntendo University (JP)
- Institute for Transfusion Medicine (US)
- Nagoya University Hospital (JP)
- Shizuoka Children's Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- Journal of Clinical Immunology
- Published
- 2026-03-28
- DOI
- https://doi.org/10.1007/s10875-026-02008-y
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00